On 2025-05-01, Fulcrum Therapeutics, Inc. (FULC) announced earnings per share of $-0.28 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.29.
The next expected annoucement date for quarterly earnings is 2025-07-30, with an average estimated earnings per share of $-0.29 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-01 | 2025-03-31 | $-0.29 | $-0.28 |
| 2025-02-25 | 2024-12-31 | $-0.28 | $-0.31 |
| 2024-11-13 | 2024-09-30 | $-0.40 | $-0.35 |
| 2024-07-31 | 2024-06-30 | $-0.06 | $0.87 |
| 2024-05-13 | 2024-03-31 | $-0.44 | $-0.43 |
| 2024-02-27 | 2023-12-31 | $-0.44 | $-0.40 |
| 2023-11-07 | 2023-09-30 | $-0.44 | $-0.39 |
| 2023-08-03 | 2023-06-30 | $-0.44 | $-0.38 |
| 2023-05-15 | 2023-03-31 | $-0.47 | $-0.41 |
| 2023-03-09 | 2022-12-31 | $-0.49 | $-0.50 |
| 2022-11-08 | 2022-09-30 | $-0.62 | $-0.50 |
| 2022-08-11 | 2022-06-30 | $-0.66 | $-0.83 |
| 2022-05-09 | 2022-03-31 | $-0.63 | $-0.64 |
| 2022-03-03 | 2021-12-31 | $-0.65 | $-0.58 |
| 2021-11-04 | 2021-09-30 | $-0.64 | $-0.57 |
| 2021-08-10 | 2021-06-30 | $-0.65 | $-0.60 |
| 2021-05-06 | 2021-03-31 | $-0.66 | $-0.54 |
| 2021-03-04 | 2020-12-31 | $-0.73 | $-0.64 |
| 2020-11-10 | 2020-09-30 | $-0.66 | $-0.70 |
| 2020-08-11 | 2020-06-30 | $-0.80 | $-0.66 |
| 2020-05-13 | 2020-03-31 | $-0.75 | $-0.81 |
| 2020-03-05 | 2019-12-31 | $-0.84 | $-0.71 |
| 2019-11-14 | 2019-09-30 | $-0.62 | $-0.97 |
| 2019-08-26 | 2019-06-30 | $-2.08 | $-9.21 |